These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Induced pluripotent stem cell-derived motor neurons from amyotrophic lateral sclerosis (ALS) patients carrying different superoxide dismutase 1 mutations recapitulate pathological features of ALS. Liu WC; Liu N; Wang Y; Huang C; Li YF; Wang H; Li XG; Deng M Chin Med J (Engl); 2021 Oct; 134(20):2457-2464. PubMed ID: 34669638 [TBL] [Abstract][Full Text] [Related]
6. 4-Aminopyridine Induced Activity Rescues Hypoexcitable Motor Neurons from Amyotrophic Lateral Sclerosis Patient-Derived Induced Pluripotent Stem Cells. Naujock M; Stanslowsky N; Bufler S; Naumann M; Reinhardt P; Sterneckert J; Kefalakes E; Kassebaum C; Bursch F; Lojewski X; Storch A; Frickenhaus M; Boeckers TM; Putz S; Demestre M; Liebau S; Klingenstein M; Ludolph AC; Dengler R; Kim KS; Hermann A; Wegner F; Petri S Stem Cells; 2016 Jun; 34(6):1563-75. PubMed ID: 26946488 [TBL] [Abstract][Full Text] [Related]
7. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology. Liu Y; Deng W Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934 [TBL] [Abstract][Full Text] [Related]
8. Modeling hallmark pathology using motor neurons derived from the family and sporadic amyotrophic lateral sclerosis patient-specific iPS cells. Sun X; Song J; Huang H; Chen H; Qian K Stem Cell Res Ther; 2018 Nov; 9(1):315. PubMed ID: 30442180 [TBL] [Abstract][Full Text] [Related]
9. Mir-17∼92 Confers Motor Neuron Subtype Differential Resistance to ALS-Associated Degeneration. Tung YT; Peng KC; Chen YC; Yen YP; Chang M; Thams S; Chen JA Cell Stem Cell; 2019 Aug; 25(2):193-209.e7. PubMed ID: 31155482 [TBL] [Abstract][Full Text] [Related]
10. Mechanistic Insights of Astrocyte-Mediated Hyperactive Autophagy and Loss of Motor Neuron Function in SOD1 Rajpurohit CS; Kumar V; Cheffer A; Oliveira D; Ulrich H; Okamoto OK; Zatz M; Ansari UA; Khanna VK; Pant AB Mol Neurobiol; 2020 Oct; 57(10):4117-4133. PubMed ID: 32676988 [TBL] [Abstract][Full Text] [Related]
11. Genetic factors affecting survival in Japanese patients with sporadic amyotrophic lateral sclerosis: a genome-wide association study and verification in iPSC-derived motor neurons from patients. Nakamura R; Tohnai G; Nakatochi M; Atsuta N; Watanabe H; Ito D; Katsuno M; Hirakawa A; Izumi Y; Morita M; Hirayama T; Kano O; Kanai K; Hattori N; Taniguchi A; Suzuki N; Aoki M; Iwata I; Yabe I; Shibuya K; Kuwabara S; Oda M; Hashimoto R; Aiba I; Ishihara T; Onodera O; Yamashita T; Abe K; Mizoguchi K; Shimizu T; Ikeda Y; Yokota T; Hasegawa K; Tanaka F; Nakashima K; Kaji R; Niwa JI; Doyu M; Terao C; Ikegawa S; Fujimori K; Nakamura S; Ozawa F; Morimoto S; Onodera K; Ito T; Okada Y; Okano H; Sobue G; J Neurol Neurosurg Psychiatry; 2023 Oct; 94(10):816-824. PubMed ID: 37142397 [TBL] [Abstract][Full Text] [Related]
12. Interleukin-17 and Th17 Lymphocytes Directly Impair Motoneuron Survival of Wildtype and FUS-ALS Mutant Human iPSCs. Jin M; Akgün K; Ziemssen T; Kipp M; Günther R; Hermann A Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360808 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA Profiling Reveals Marker of Motor Neuron Disease in ALS Models. Hoye ML; Koval ED; Wegener AJ; Hyman TS; Yang C; O'Brien DR; Miller RL; Cole T; Schoch KM; Shen T; Kunikata T; Richard JP; Gutmann DH; Maragakis NJ; Kordasiewicz HB; Dougherty JD; Miller TM J Neurosci; 2017 May; 37(22):5574-5586. PubMed ID: 28416596 [TBL] [Abstract][Full Text] [Related]
14. Edaravone activates the GDNF/RET neurotrophic signaling pathway and protects mRNA-induced motor neurons from iPS cells. Li Q; Feng Y; Xue Y; Zhan X; Fu Y; Gui G; Zhou W; Richard JP; Taga A; Li P; Mao X; Maragakis NJ; Ying M Mol Neurodegener; 2022 Jan; 17(1):8. PubMed ID: 35012575 [TBL] [Abstract][Full Text] [Related]
15. Human Motor Neurons With SOD1-G93A Mutation Generated From CRISPR/Cas9 Gene-Edited iPSCs Develop Pathological Features of Amyotrophic Lateral Sclerosis. Kim BW; Ryu J; Jeong YE; Kim J; Martin LJ Front Cell Neurosci; 2020; 14():604171. PubMed ID: 33328898 [TBL] [Abstract][Full Text] [Related]
16. Autologous treatment for ALS with implication for broad neuroprotection. Kim D; Kim S; Sung A; Patel N; Wong N; Conboy MJ; Conboy IM Transl Neurodegener; 2022 Mar; 11(1):16. PubMed ID: 35272709 [TBL] [Abstract][Full Text] [Related]